guanosine 3':5'-cyclic monophosphate sodium salt
guanosine 3':5'-cyclic monophosphate sodium salt structure
|
Common Name | guanosine 3':5'-cyclic monophosphate sodium salt | ||
|---|---|---|---|---|
| CAS Number | 40732-48-7 | Molecular Weight | 367.187 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C10H11N5NaO7P | Melting Point | N/A | |
| MSDS | USA | Flash Point | N/A | |
Use of guanosine 3':5'-cyclic monophosphate sodium saltCyclic GMP sodium (cGMP) is an important regulator of short-term changes in smooth muscle tone and longer-term responses to chronic drug treatment or proliferative signals, it is in response to atrial natriuretic peptide (ANP) or nitric oxide (NO). Cyclic GMP sodium interacts with cation channels to regulate ion transport or activate the cyclic GMP-dependent protein kinase to result in protein phosphorylation[1][2]. |
| Name | Guanosine 3’,5’-Cyclic Monophosphate Sodium Salt |
|---|---|
| Synonym | More Synonyms |
| Description | Cyclic GMP sodium (cGMP) is an important regulator of short-term changes in smooth muscle tone and longer-term responses to chronic drug treatment or proliferative signals, it is in response to atrial natriuretic peptide (ANP) or nitric oxide (NO). Cyclic GMP sodium interacts with cation channels to regulate ion transport or activate the cyclic GMP-dependent protein kinase to result in protein phosphorylation[1][2]. |
|---|---|
| Related Catalog | |
| Target |
Human Endogenous Metabolite |
| Molecular Formula | C10H11N5NaO7P |
|---|---|
| Molecular Weight | 367.187 |
| Exact Mass | 367.029388 |
| PSA | 187.45000 |
| Storage condition | −20°C |
| Water Solubility | H2O: 50 mg/mL |
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
| HS Code | 29349990 |
|
H89 enhances the sensitivity of cancer cells to glyceryl trinitrate through a purinergic receptor-dependent pathway.
Oncotarget 6(9) , 6877-86, (2015) High doses of the organic nitrate glyceryl trinitrate (GTN), a nitric oxide (NO) donor, are known to trigger apoptosis in human cancer cells. Here, we show that such a cytotoxic effect can be obtained... |
|
|
Atrial natriuretic peptide inhibits cell cycle activity of embryonic cardiac progenitor cells via its NPRA receptor signaling axis.
Am. J. Physiol. Cell Physiol. 308(7) , C557-69, (2015) The biological effects of atrial natriuretic peptide (ANP) are mediated by natriuretic peptide receptors (NPRs), which can either activate guanylyl cyclase (NPRA and NPRB) or inhibit adenylyl cyclase ... |
|
|
Safety, pharmacokinetics and neutralization of the broadly neutralizing HIV-1 human monoclonal antibody VRC01 in healthy adults.
Clin. Exp. Immunol. 182 , 289-301, (2015) VRC-HIVMAB060-00-AB (VRC01) is a broadly neutralizing HIV-1 monoclonal antibody (mAb) isolated from the B cells of an HIV-infected patient. It is directed against the HIV-1 CD4 binding site and is cap... |
| Guanosine 3',5'-Cyclic Monophosphate Sodium Salt |
| EINECS 255-056-0 |
| Sodium (4aR,6R,7R,7aS)-6-(2-amino-6-oxo-3,6-dihydro-9H-purin-9-yl)-7-hydroxytetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-2-olate 2-oxide |
| 6H-Purin-6-one, 2-amino-3,9-dihydro-9-[(4aR,6R,7R,7aS)-tetrahydro-2,7-dihydroxy-2-oxido-4H-furo[3,2-d]-1,3,2-dioxaphosphorin-6-yl]-, sodium salt (1:1) |
| MFCD00038424 |